Disclosure of Commercial Interest

The following faculty members and planners have indicated that they do not have a financial relationship with a commercial organization that may have a direct or indirect interest in the subject matter being presented, or with any commercial organization that has provided funds for the educational activity has nothing to disclose:

  • Kerry Davis has nothing to disclose. 
  • Homer Macapinlac has nothing to disclose. 
  • Courtney Moreno has nothing to disclose. 
  • Gang Niu has nothing to disclose.
  • Daniel J. Lee has nothing to disclose.
  • Catherine Petchprapa has nothing to disclose. 
  • Samantha Schulz has nothing to disclose.
  • Andrew Scott has nothing to disclose.
  • Lubdha Shah has nothing to disclose.
  • Jean-Luc Urbain has nothing to disclose.

The following individuals have indicated that they have a disclosure of commercial interest:

  • Thomas Hope receives consulting fees from Blue Earth and Curium. 
  • Heather Jacene receives consulting fees as part of the Consulting-Advisory Board for Advanced Accelerator Applications. Dr. Jacene receives a speaker honorarium from Australian and New Zealand Urogenital and Prostate Cancer clinical trial group and Janssen Pharmaceuticals. She receives research support from Siemens Healthcare and GTx, Inc.
  • Reginald Munden is a member of the advisory board for Optellum, Ltd and receives invested stocks for TheraBionics. 
  • Pat Zanzonico receives lecture fees from Novartis. He also receives consulting fees from Radionetics.